Search - Université Clermont Auvergne Access content directly

Filter your results

18 Results
authFullName_s : G. Fond

Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort

O. Godin , M. Leboyer , F. Schürhoff , L. Boyer , M. Andrianarisoa et al.
Journal of Psychiatric Research, In press, 94, pp.62 - 69. ⟨10.1016/j.jpsychires.2017.06.008⟩
Journal articles hal-01696840v1
Image document

Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohort

G. Fond , L. Boyer , F. Schürhoff , F. Berna , O. Godin et al.
Schizophrenia Research, 2018, 201, pp.373-380. ⟨10.1016/j.schres.2018.05.007⟩
Journal articles hal-02094446v1
Image document

Centres Experts Schizophrénie, un outil pour le soin et la recherche : retour sur 10 ans d’expérience

O. Godin , L. Boyer , I. Chereau , M. Andrianarisoa , Bruno Aouizerate et al.
L'Encéphale, 2019, 45 (1), pp.9-14. ⟨10.1016/j.encep.2018.07.007⟩
Journal articles hal-03173251v1

Birth by cesarean section and schizophrenia: results from the multicenter FACE-SZ data-set

G. Fond , E. Bulzacka , L. Boyer , P. Llorca , O. Godin et al.
European Archives of Psychiatry and Clinical Neuroscience, 2017, 267 (6), pp.587-594. ⟨10.1007/s00406-016-0708-3⟩
Journal articles hal-02174753v1

A double amino-acid change in the HLA-A peptide-binding groove is associated with response to psychotropic treatment in patients with schizophrenia

S. Le Clerc , L Taing , G. Fond , A Meary , L Llorca et al.
Translational Psychiatry, 2015, 5 (7), pp.e608-e608. ⟨10.1038/tp.2015.97⟩
Journal articles hal-02173642v1

Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohort

G. Fond , O. Godin , F. Schürhoff , F. Berna , Bruno Aouizerate et al.
Journal of Affective Disorders, 2019, 245, pp.468-474. ⟨10.1016/j.jad.2018.11.004⟩
Journal articles hal-02094172v1

Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset

G. Fond , L. Boyer , M. Favez , L. Brunel , Bruno Aouizerate et al.
Psychopharmacology, 2016, 233 (4), pp.571 - 578. ⟨10.1007/s00213-015-4167-8⟩
Journal articles hal-01885753v1

Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort

G. Fond , E. Bulzacka , M. Boucekine , F. Schürhoff , F. Berna et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2019, 92 (8), pp.8-18. ⟨10.1016/j.pnpbp.2018.12.005⟩
Journal articles hal-02094189v1
Image document

A National network of schizophrenia expert centres: An innovative tool to bridge the research-practice gap

F. Schürhoff , G. Fond , F. Berna , E. Bulzacka , J. Vilain et al.
European Psychiatry, 2015, 30 (6), pp.728--735. ⟨10.1016/j.eurpsy.2015.05.004⟩
Journal articles hal-01985795v1

Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort

G. Fond , N. Resseguier , F. Schürhoff , O. Godin , M. Andrianarisoa et al.
European Archives of Psychiatry and Clinical Neuroscience, In press, ⟨10.1007/s00406-017-0847-1⟩
Journal articles hal-01696697v1

Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohort

G. Fond , L. Boyer , M. Leboyer , O. Godin , P. Llorca et al.
Schizophrenia Research, 2017, ⟨10.1016/j.schres.2017.09.027⟩
Journal articles hal-01696800v1

Early-life factors associated with increased risk of disability pension in the national real-world schizophrenia FACE-SZ cohort study

G. Fond , J. Dubreucq , P. de Verville , O. Godin , C. Andrieu-Haller et al.
European Archives of Psychiatry and Clinical Neuroscience, 2022, ⟨10.1007/s00406-021-01364-7⟩
Journal articles hal-03625050v1

3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort

O. Godin , B. Pignon , A. Szoke , L. Boyer , B. Aouizerate et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2023, 120, pp.110641. ⟨10.1016/j.pnpbp.2022.110641⟩
Journal articles inserm-03890576v1

Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort

J. Mallet , Y. Le Strat , F. Schürhoff , N. Mazer , C. Portalier et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2017, 79, pp.332 - 339. ⟨10.1016/j.pnpbp.2017.06.026⟩
Journal articles hal-01696847v1

Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset

F. Berna , D. Misdrahi , L. Boyer , Bruno Aouizerate , L. Brunel et al.
Schizophrenia Research, 2015, 169 (1-3), pp.255 - 261. ⟨10.1016/j.schres.2015.10.040⟩
Journal articles hal-01896595v1

Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ dataset

G. Fond , L. Boyer , M. Andrianarisoa , O. Godin , L. Brunel et al.
Schizophrenia Research, 2018, ⟨10.1016/j.schres.2017.08.058⟩
Journal articles hal-01696808v1

La psychiatrie doit jouer un rôle majeur dans l’amélioration des indicateurs de santé publique en France

G. Fond , M. Masson , P. Auquier , D. da Fonséca , C. Lançon et al.
L'Encéphale, 2019, 45 (2), pp.99-100. ⟨10.1016/j.encep.2019.01.002⟩
Journal articles hal-02094228v1

Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort

G. Fond , O. Godin , F. Schürhoff , F. Berna , M. André et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2020, 101, pp.1-9. ⟨10.1016/j.pnpbp.2020.109927⟩
Journal articles hal-02903523v1